{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-036109","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2026-08-05T12:30:20+00:00","discovered_at":"2026-08-05T12:35:02.919863+00:00","generated_at":"2026-08-05T12:35:29.479225+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Dermata announces Aug 25 launch of Tome Foundational Treatment at $178 per set","bullets":["First commercial product Tome Foundational Treatment launches August 25, 2026; waitlist gets early preorder access.","Four once-weekly treatments per set, priced at $178 (approx $45/treatment), sold exclusively at tomeskincare.com.","Company shifts to commercialize skincare products, reducing regulatory burdens and expanding consumer market."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-036109","json":"https://secwatch.observer/filing/0001493152-26-036109.json","markdown":"https://secwatch.observer/filing/0001493152-26-036109.md","text":"https://secwatch.observer/filing/0001493152-26-036109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000149315226036109/0001493152-26-036109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000149315226036109/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T12:35:29.479225+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}